Sledenje bolnikov z rakom debelega črevesa in danke po radikalnem zdravljenju

Show document
A+ | A- | | SLO | ENG

Title:	Sledenje bolnikov z rakom debelega črevesa in danke po radikalnem zdravljenju
Authors:	ID Oblak, Irena (Author)
Files:	PDF - Presentation file, download (311,87 KB) MD5: 857CBB0A41BC0C1D449951CC8BE0DEC4 PID: 20.500.12556/dirros/cf8ffc74-a39a-4c8a-9325-4670a769c97a
Language:	Slovenian
Typology:	1.08 - Published Scientific Conference Contribution
Organization:	OI - Institute of Oncology
Keywords:	bolniki, rak debelega črevesa, rak danke, rak prebavil
Publication status:	Published
Publication version:	Version of Record
Year of publishing:	2013
Number of pages:	str. 37-38, 76
Numbering:	Letn. 17, št. 1
PID:	20.500.12556/DiRROS-9030
UDC:	616.3-006
ISSN on article:	1408-1741
URN:	URN:NBN:SI:doc-MMKGNA7W
COBISS.SI-ID:	1554811
Copyright:	by Authors
Publication date in DiRROS:	31.08.2018
Views:	3862
Downloads:	952
Metadata:
:	OBLAK, Irena, 2013, Sledenje bolnikov z rakom debelega črevesa in danke po radikalnem zdravljenju. In : Šola tumorjev prebavil, Ljubljana, 30. 11. 2012 [online]. Published Scientific Conference Contribution. 2013. p. 37–38, 76. [Accessed 18 November 2025]. Retrieved from: https://dirros.openscience.si/IzpisGradiva.php?lang=eng&id=9030 Copy citation

Share:

Searching for similar works... Please wait....

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Title:	Šola tumorjev prebavil, Ljubljana, 30. 11. 2012
Publisher:	Onkološki inštitut
COBISS.SI-ID:	1553275

License:	CC BY 4.0, Creative Commons Attribution 4.0 International

Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Language:	English
Title:	Follow-up of colorectal cancer patients after radical treatment
Abstract:	After completed treatment, either surgical or combined treatment of colorectal carcinoma, it is necessary to follow up patients regularly and in accordance with the recommended protocol. The purpose of such follow-up is to detect the disease or its recurrence as early as possible, including pre-cancerous lesions or potential metachronous (newly developed) tumours which can be treated successfully at an early stage. Follow-up is important also for the treatment of late complications, it enables psychological support to the patients, and finally, we can also track and assess our own performance. It is known that colorectal cancer recurs in 30 do 50% of patients. As many as 70% of recurrences are detected within the first two years, 80% in the first three years, and 90% or more disease recurrences are found within five years after surgery of the primary tumour. It has been shown that regular follow-up of patients after their treatment improves the outcome of their disease and reduces mortality in patients by 9% to 13%. We must adapt it to each patient separately, taking into account both his age and general condition, stage of the disease, concurrent diseases, and further treatment possibilities in the event of a recurrence.